Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MediWound (MDWD) Interest Expenses (2016 - 2025)

MediWound has reported Interest Expenses over the past 13 years, most recently at -$8.0 million for Q2 2025.

  • For Q2 2025, Interest Expenses fell 232.35% year-over-year to -$8.0 million; the TTM value through Dec 2025 reached -$8.0 million, down 232.35%, while the annual FY2025 figure was $2.5 million, 80.79% down from the prior year.
  • Interest Expenses for Q2 2025 was -$8.0 million at MediWound, down from -$2.4 million in the prior quarter.
  • Over five years, Interest Expenses peaked at -$399000.0 in Q2 2021 and troughed at -$8.0 million in Q2 2025.
  • A 5-year average of -$1.5 million and a median of -$687000.0 in 2022 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: tumbled 1098.11% in 2021 and later surged 53.24% in 2022.
  • Year by year, Interest Expenses stood at -$635000.0 in 2021, then soared by 35.75% to -$408000.0 in 2022, then crashed by 118.87% to -$893000.0 in 2023, then tumbled by 169.32% to -$2.4 million in 2024, then plummeted by 232.35% to -$8.0 million in 2025.
  • Business Quant data shows Interest Expenses for MDWD at -$8.0 million in Q2 2025, -$2.4 million in Q2 2024, and -$893000.0 in Q2 2023.